James M. Hindman

Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.

James M. Hindman

James M. Hindman

Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.

Overview
Career Highlights

Allergan Specialty Therapeutics, Inc.
Allergan, Inc.
The Allergan Foundation

RelSci Relationships

1727

Number of Boards

11

Birthday

1961

Age

59

Number of Awards

1

Relationships
RelSci Relationships are individuals James M. Hindman likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at International Council of Ophthalmology Foundation

Relationship likelihood: Strong

Co-Founder, President & Chief Executive Officer at Millendo Therapeutics US, Inc.

Relationship likelihood: Strong

Former Executive Vice President, Finance & Business Development & Chief Financial Officer at Allergan, Inc.

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at The Allergan Foundation

Relationship likelihood: Strong

President & Chief Executive Officer at Tobira Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Sarepta Therapeutics, Inc.

Relationship likelihood: Strong

Chief Legal Officer & Secretary at STAAR Surgical Co.

Relationship likelihood: Strong

Executive Vice President-Human Resources at Ingram Micro, Inc.

Relationship likelihood: Strong

Founder at Regenesis Bioremediation Products, Inc.

Relationship likelihood: Strong

Former Vice President of Sales & Marketing at VIVUS, Inc.

Relationship likelihood: Strong

Paths to James M. Hindman
Potential Connections via
Relationship Science
You
James M. Hindman
Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.
Education
Class of 1988

Pepperdine is a Christian university committed to the highest standards of academic excellence and Christian values, where students are strengthened for lives of purpose, service, and leadership.

B.S. in Accounting
Class of 1982

Founded in 1911, LMU is a premier Catholic university rooted in the Jesuit and Marymount traditions. Our enrollment includes 6,087 undergraduate, 2,220 graduate and 1,236 law school students. Our 142-acre bluff-top campus is located in West Los Angeles and is among the nation's most beautiful and green campuses.

M.B.A.

Graziadio School Mission Statement The University's founder, George Pepperdine, was motivated by a desire to help men and women prepare themselves for a life of usefulness in a competitive world. He particularly advocated a business education, coupled with the development of Christian character. It is his outlook which serves to anchor the mission of the business school. Mission Statement: The mission of the George L. Graziadio School of Business and Management is to develop values-centered leaders and advance responsible business practice through education that is entrepreneurial in spirit, ethical in focus, and global in orientation. As a professional school growing out of the tradition of a Christian University, we seek to positively impact both society at large, and the organizations and communities in which our students and graduates are members. Therefore, we affirm a higher purpose for business practice than the exclusive pursuit of shareholder wealth. We believe that successful management seeks collective good along with individual profit and is anchored in core values such as integrity, stewardship, courage, and compassion.

Career History
Chief Financial Officer
Tenure Unconfirmed

Allergan Specialty Therapeutics, Inc., part of Allergan Plc, is a company headquartered in Irvine, CA. The firm develops pharmaceutical products based on retinoid and neuroprotective technologies. On 23 Apr 01 Allergan, Inc. acquired Allergan Specialty Therapeutics, Inc. for $71.02 million.

Treasurer & Vice President
Prior - 2015

Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA.

President & Director
2009 - 2015
Boards & Committees
Treasurer
Current

Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA.

Member, Accounting Advisory Board
2007 - Current
Member, Board of Directors
2009 - 2016
Political Donations
$2,300
2007

Former President of United States

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James M. Hindman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James M. Hindman's profile does not indicate a business or promotional relationship of any kind between RelSci and James M. Hindman.